Range Advisory, LLC’s Novo Nordisk NVO Stock Holding History

Range Advisory, LLC’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$213K	Buy	+4,440	New	+$191K	0.03%	326

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Range Advisory, LLC's NVO Position: Q2 2026 in Review

Range Advisory, LLC opened a new position in Novo Nordisk (NVO) in Q2 2026: 4,440 shares worth $213K. The stake represents 0.03% of the portfolio and ranks #326 among its holdings.

1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Range Advisory, LLC held 4,440 shares of Novo Nordisk worth $213K as of Q2 2026.
Novo Nordisk was a new Range Advisory, LLC position in Q2 2026.
Novo Nordisk made up 0.03% of Range Advisory, LLC's portfolio in Q2 2026, its #326 holding.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Range Advisory, LLC's 13F filing for Q2 2026, filed 2 Sep 2026.